Neuromuscular Blocking Agents Flashcards
Motor nerves release ____ onto ____ receptors
neuromuscular nicotinic receptors mediate skeletal muscle contraction in response to acetylcholine
Somatic Nerves emanate from the ______ and innervate ______ with ___ synapses outside the CNS
Somatic Nerves emanate from the spinal cord and innervate skeletal muscle with no synapses outside the CNS
Somatic nerve signal terminated by:
Signal is terminated by degradation of Acetylcholine - by Acetylcholinesterases
Anticholinesterases are useful in treating ____________
Anticholinesterases are useful in treating Myasthenia gravis
___________ are useful in treating Myasthenia gravis
Anticholinesterases are useful in treating Myasthenia gravis
Acetylcholine + Acetylcholinesterase –>
Acetate + Choline
Acetylcholine at nicotinic receptor results in …. (pathway)
Na influx
Depolarization
muscle action potential
opening of voltage-sensitive Ca2+ channel
release of Ca2+ from sarcoplasmic reticulum
contraction
Nicotinic receptor historically blocked by
historically blocked by alpha-bungarotoxin from krait or cobra (Naja naja) venom (snake)
Agents prolonging Acetylcholine action (____, _____, _____) _______ muscle depolarization & contraction
Agents prolonging Acetylcholine action (Neostigmine, Pyridostigmine, Edrophonium) augment muscle depolarization & contraction- relevant to Myasthenia gravis
Agents blocking acetycholine release (_______) will prevent both _____ & _______
Agents blocking acetycholine release (Botulinum toxin) will prevent both muscle depolarization & contraction- relevant to cosmetics, muscle spasms
nicotinic receptor blockers (_____, ________) will prevent both ___________ & _________
nicotinic receptor blockers (d-tubocurarine, Mivacurium) will prevent both muscle depolarization & contraction- relevant to surgical paralysis
Something that blocks calcium-induced calcium release (________) will block ________ but not _______
Something that blocks calcium-induced calcium release (Dantrolene) will block contraction but not depolarization- relevant to Malignant Hyperthermia
Autoimmune disease resulting in destruction of nicotinic receptors on skeletal muscle
Myasthenia gravis
Treatment for myasthenia gravis
Treatment includes anticholinesterases (pyridostigmine, neostigmine)
Diagnosis for myasthenia gravis
Diagnosis can include the short acting anticholinesterase edrophonium (Tensilon test)
(Mestinon, Regonol) - used in myasthenia gravis or to reverse competitive neuromuscular antagonism; can be used prophylactically to prevent actions of nerve gases (tabun, soman)
Pyridostigmine
(Prostigmin)- used in myasthenia gravis but poorly absorbed from the gut; used more in hospitalized patients
Neostigmine
used to diagnose myasthenia gravis (vs. cholinergic crisis)
Edrophonium (Tensilon injectable)
increases strength in a myasthenic crisis and decreases strength in a cholinergic crisis (too much acetylcholine)
principal behind a cholinergic crisis
nicotinic receptor - excessive stimulation of nicotinic receptors desensitizes organ to further stimulation
Toxicity of anticholinesterases
SLUDGE (sweating, lacrimation, urination, diarrhea, GI distress, emesis)
Used primarily in surgery to paralyze skeletal muscle
Neuromuscular blockers
What do neuromuscular blockers block?
block nicotinic receptors on skeletal muscle
Two types neuromuscular blockers?
Competitive, depolarizing
Competitive blockers (eg)
d-tubocurarine, pancuronium, vecuronium, atracurium, metocurine, pipecuronium, mivacurium, rocuronium
Depolarizing agents (Eg)
succinylcholine
Mechanism of competitive blockers
competitive compete for nicotinic receptor sites - block Na+ influx, depolarization and contraction
Succinylcholine mechanism
depolarizes end plate of muscle- chronic Na+ influx causes depolarization; fasciculations precede flaccid paralysis
Anticholinesterases reverse block of ______
Competitive blockers
Anticholinesterases may augment block of _________
Depolarizing blockers
Fasciculations precede flaccid paralysis by ________
Depolarizing blockers
___________ agents release K
Depolarizing agents
Ether, halogenated anesthetics, streptomycin, tetracycline ________ competitive block
Ether, halogenated anesthetics, streptomycin, tetracycline enhance competitive block
Anticholinesterases- _________ competitive blocker but __________ a depolarizing blocker
Anticholinesterases- antagonize competitive blocker but potentiate a depolarizing blocker
epinephrine and norepinephrine - slight ability to reverse _____________
epinephrine and norepinephrine - slight ability to reverse competitive blockade
Toxic effects of neuromuscular blockers
Apnea, histamine release, cardiovascular collapse
Malignant hyperthermia caused by halothane and succinylcholine
Tx for malignant hyperthermia
treatment is dantrolene (dantrium) - inhibits Ca2+ release from sarcoplasmic reticulum by blocking the Ryanodine receptor (Calcium-induced calcium release)
Uses for neuromuscular blockers
with anesthetics; prevention of seizures in electroshock therapy; nerve root pain vs muscle spasm impinging on nerve
Absorption, metabolism of neuromuscular blockers
Absorption- Quaternary ammonium (i.v.); Metabolism - usually by kidneys except atracurium
Depolarizing agents - avoid use in ____ patients, why
Avoid in burn patients (burned muscle increases the concentration of nicotinic receptors resulting in excessive potassium release in response to succinylcholine)
Usually used for tracheal intubation to prevent aspiration of gastric contents; __________ is preferred for this because of its rapid action
succinylcholine
Can produce malignant hyperthermia -treat with calcium antagonist, dantrolene
succinylcholine
Succinylcholine has ______ duration of action
Short duration of action because of rapid metabolism (butyrylcholinesterase)
Botulinum toxin mechanism
Prevents acetylcholine release by cleaving proteins (SNAP25) necessary for acetylcholine exocytosis